Search by Drug Name or NDC
NDC 16729-0525-03 ATROPINE SULFATE 0.4 mg/mL Details
ATROPINE SULFATE 0.4 mg/mL
ATROPINE SULFATE is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is ATROPINE SULFATE.
Product Information
| NDC | 16729-0525 |
|---|---|
| Product ID | 16729-525_f7056bbf-1020-054c-e053-6394a90a3ef3 |
| Associated GPIs | 49101010102022 |
| GCN Sequence Number | 081567 |
| GCN Sequence Number Description | atropine sulfate VIAL 0.4 MG/ML INTRAVEN |
| HIC3 | J2A |
| HIC3 Description | BELLADONNA ALKALOIDS |
| GCN | 48724 |
| HICL Sequence Number | 002004 |
| HICL Sequence Number Description | ATROPINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | ATROPINE SULFATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ATROPINE SULFATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.4 |
| Active Ingredient Units | mg/mL |
| Substance Name | ATROPINE SULFATE |
| Labeler Name | Accord Healthcare Inc. |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA214652 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16729-0525-03 (16729052503)
| NDC Package Code | 16729-525-03 |
|---|---|
| Billing NDC | 16729052503 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (16729-525-03) / 1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-10-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |